Status:
COMPLETED
A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
Lead Sponsor:
AbbVie
Conditions:
Masseter Muscle Prominence
Eligibility:
All Genders
18-64 years
Phase:
PHASE3
Brief Summary
The masseter muscle is one of the muscles in the lower face used for chewing. Prominence of the masseter muscle can appear as a widened and square lower face shape, which is an aesthetic concern for i...
Eligibility Criteria
Inclusion
- Adult Japanese individuals.
- Participant with marked or very marked masseter muscle prominence (MMP).
Exclusion
- Asymmetry of left and right sides of the face that could prevent identical Masseter Muscle Prominence Scale (MMPS) or MMPS-P grading on both sides of the face, as determined by the investigator.
- History of permanent soft tissue fillers in the jawline.
Key Trial Info
Start Date :
November 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT06137287
Start Date
November 22 2023
End Date
July 31 2025
Last Update
August 22 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Jyosui Dermatology Clinic /ID# 254300
Fukuoka, Fukuoka, Japan, 810-0022
2
Kotoni Tower Skin And Cosmetic Surgery Clinic /ID# 260668
Sapporo, Hokkaido, Japan, 063-0812
3
Tokai University Hospital /ID# 254204
Isehara, Kanagawa, Japan, 259-1193
4
Yoshikawa Skin Ecru Clinic /ID# 256505
Kyoto, Kyoto, Japan, 604-8035